Catalyst Wire Dossier Catalyst Wire Dossier

KB304

· Krystal Biotech, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KB304, covering 2025-05-13 to 2025-05-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study Assessing KB304 for the Treatment of Wrinkles in Women [Phase 1, Phase 2]

See pricing